Literature DB >> 15827760

The key role of apolipoprotein E in atherosclerosis.

Kirsty Greenow1, Nigel J Pearce, Dipak P Ramji.   

Abstract

Apolipoprotein E is a multifunctional protein that is synthesized by the liver and several peripheral tissues and cell types, including macrophages. The protein is involved in the efficient hepatic uptake of lipoprotein particles, stimulation of cholesterol efflux from macrophage foam cells in the atherosclerotic lesion, and the regulation of immune and inflammatory responses. Apolipoprotein E deficiency in mice leads to the development of atherosclerosis and re-expression of the protein reduces the extent of the disease. This review presents evidence for the potent anti-atherogenic action of apolipoprotein E and describes our current understanding of its multiple functions and regulation by factors implicated in the pathogenesis of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827760     DOI: 10.1007/s00109-004-0631-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  178 in total

1.  A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele.

Authors:  S Mui; M Briggs; H Chung; R B Wallace; T Gomez-Isla; G W Rebeck; B T Hyman
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

Review 2.  The cell biology and physiologic relevance of ApoE recycling.

Authors:  S Fazio; M F Linton; L L Swift
Journal:  Trends Cardiovasc Med       Date:  2000-01       Impact factor: 6.677

3.  Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men.

Authors:  Jarkko Karvonen; Heikki Kauma; Kari Kervinen; Olavi Ukkola; Maire Rantala; Markku Päivänsalo; Markku J Savolainen; Y Antero Kesäniemi
Journal:  J Hypertens       Date:  2002-12       Impact factor: 4.844

4.  Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction.

Authors:  A Batalla; R Alvarez; J R Reguero; S Hevia; G Iglesias-Cubero; V Alvarez; A Cortina; P González; M M Celada; A Medina; E Coto
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

5.  Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study.

Authors:  S E Humphries; P J Talmud; E Hawe; M Bolla; I N Day; G J Miller
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

6.  The effectiveness of hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) in the elderly is not influenced by apolipoprotein E genotype.

Authors:  Anke-Hilse Maitland-van der Zee; Bruno H Stricker; Olaf H Klungel; John J Kastelein; Albert Hofman; Jacqueline C Witteman; Monique M Breteler; Hubertus G Leufkens; Cornelia M van Duijn; Anthonius de Boer
Journal:  Pharmacogenetics       Date:  2002-11

Review 7.  Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

Authors:  Simon M Laws; Eugene Hone; Sam Gandy; Ralph N Martins
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

8.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

Authors:  M E Kelly; M A Clay; M J Mistry; H M Hsieh-Li; J A Harmony
Journal:  Cell Immunol       Date:  1994-12       Impact factor: 4.868

10.  Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.

Authors:  C C Walden; M W Huff; L A Leiter; P W Connelly; R A Hegele
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

View more
  61 in total

Review 1.  Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis.

Authors:  I Peter; M D Crosier; M Yoshida; S L Booth; L A Cupples; B Dawson-Hughes; D Karasik; D P Kiel; J M Ordovas; T A Trikalinos
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

Review 2.  Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.

Authors:  K Mahdy Ali; A Wonnerth; K Huber; J Wojta
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  A dysregulation in CES1, APOE and other lipid metabolism-related genes is associated to cardiovascular risk factors linked to obesity.

Authors:  M Pilar Marrades; Pedro González-Muniesa; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Obes Facts       Date:  2010-10-15       Impact factor: 3.942

Review 4.  Genetic determinants of arterial stiffness.

Authors:  Jeongok G Logan; Mary B Engler; Hyungsuk Kim
Journal:  J Cardiovasc Transl Res       Date:  2014-12-04       Impact factor: 4.132

5.  TNFα and Reactive Oxygen Signaling in Vascular Smooth Muscle Cells in Hypertension and Atherosclerosis.

Authors:  Fred S Lamb; Hyehun Choi; Michael R Miller; Ryan J Stark
Journal:  Am J Hypertens       Date:  2020-10-21       Impact factor: 2.689

6.  High serum apolipoprotein E determines hypertriglyceridemic dyslipidemias, coronary disease and apoA-I dysfunctionality.

Authors:  Altan Onat; Günay Can; Ender Ornek; Erkan Ayhan; Nihan Erginel-Ünaltuna; Sani N Murat
Journal:  Lipids       Date:  2012-10-25       Impact factor: 1.880

7.  The cloning, characterization, and expression profiling of the LRP8 gene in duck (Anas platyrhynchos).

Authors:  Shenqiang Hu; Hehe Liu; Zhixiong Pan; Fang Ding; Jie Kou; Liang Li; Jiwen Wang
Journal:  Mol Cell Biochem       Date:  2012-12-07       Impact factor: 3.396

8.  The relative atherogenicity of VLDL and LDL is dependent on the topographic site.

Authors:  Eline Van Craeyveld; Frank Jacobs; Yingmei Feng; Leen C J Thomassen; Johan A Martens; Joke Lievens; Jan Snoeys; Bart De Geest
Journal:  J Lipid Res       Date:  2010-01-19       Impact factor: 5.922

Review 9.  The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture.

Authors:  Andrew R Bond; Christopher L Jackson
Journal:  J Biomed Biotechnol       Date:  2010-11-07

10.  Protein kinase C controls vesicular transport and secretion of apolipoprotein E from primary human macrophages.

Authors:  Denuja Karunakaran; Maaike Kockx; Dylan M Owen; John R Burnett; Wendy Jessup; Leonard Kritharides
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.